MarketScreener Homepage > Equities > Xetra > Fresenius Medical Care AG & Co. KGaA FME DE0005785802

Report

Delayed Xetra - 10/23 11:35:03 am
68.64	EUR		+2.08%

10/23

FRESENIUS SE : Receives a Buy rating from Goldman Sachs

10/23

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Buy rating from Goldman Sachs

10/22

FRESENIUS SE : Credit Suisse reiterates its Neutral rating

Calendar

Upcoming events on FRESENIUS MEDICAL CARE AG & CO. KGAA

10/29/20		Q3 2020 Earnings Release
10/29/20		Q3 2020 Earnings Call
02/24/21		FY 2020 Earnings Release (Projected)
05/05/21		Q1 2021 Earnings Release (Projected)

Past events on FRESENIUS MEDICAL CARE AG & CO. KGAA

10/08/20 \| 08:00am		Capital Markets Day
08/28/20		Ex-dividend day for final dividend
08/27/20		Annual General Meeting
07/30/20 \| 10:30am		Interim 2020 Earnings Call

Upcoming sector events for FRESENIUS MEDICAL CARE AG & CO. KGAA

10/26/20		HCA HEALTHCARE, INC. : Q3 2020 Earnings Release
10/27/20		TOPCHOICE MEDICAL CORPORATION : Q3 2020 Earnings Release
10/27/20		AIER EYE HOSPITAL GROUP CO., LTD. : Q3 2020 Earnings Release
10/27/20 \| 09:00am		LABORATORY CORPORATION OF AMERICA HOLDINGS : Q3 2020 Earnings Call

More events

Past sector events for FRESENIUS MEDICAL CARE AG & CO. KGAA

10/22/20 \| 09:30am		QUEST DIAGNOSTICS INCORPORATED : Q3 2020 Earnings Call
10/22/20 \| 07:45am		QUEST DIAGNOSTICS INCORPORATED : Q3 2020 Earnings Release
10/21/20		UNIVERSAL HEALTH SERVICES, INC. : Q3 2020 Earnings Release (Projected)
10/13/20 \| 07:25pm		SONIC HEALTHCARE LIMITED : September 2020 Sales and Revenue Release - Trading Update

Annual publications

Annual results		2015	2016	2017	2018	2019	2020 (e)
Sales M $	Released Forecast Spread	16 738 16 823 -0,51%	17 911 17 952 -0,23%	21 893 21 170 3,4%	18 750 18 753 -0,02%	18 861 19 156 -1,5%	21 508
Operating income (EBITDA) M $	Released Forecast Spread	3 105 3 122 -0,53%	3 413 3 409 0,13%	3 814 3 912 -2,5%	4 234 3 764 12%	4 169 4 058 2,7%	4 636
Operating profit (EBIT) M $	Released Forecast Spread	2 388 2 389 -0,05%	2 638 2 632 0,22%	2 908 3 051 -4,7%	3 442 3 117 10%	2 450 2 527 -3,1%	2 895
Pre-Tax Profit (EBT) M $	Released Forecast Spread	1 936 1 976 -2,0%	2 232 2 227 0,23%	2 472 2 691 -8,1%	3 101 2 919 6,2%	1 987 2 097 -5,2%	2 439
Net income M $	Released Forecast Spread	1 029 1 065 -3,4%	1 243 1 229 1,1%	1 576 1 658 -5,0%	2 246 1 971 14%	1 295 1 317 -1,6%	1 548
EPS $	Released Forecast Spread	3,38 3,49 -3,1%	4,07 4,02 1,3%	5,13 5,26 -2,3%	7,33 6,78 8,1%	4,27 4,36 -2,0%	5,28
Announcement Date		02/24/2016	02/22/2017	02/26/2018	02/20/2019	02/20/2020

Quarterly publications

Previous period

Next period

Quarterly results		2016 S1	2017 S1	2018 Q1	2018 Q2	2018 S1	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3 (e)	2020 Q4 (e)	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)
Sales M $	Released Forecast Spread	8 626 8 611 0,17%	10 642 10 521 1,2%	4 754 4 869 -2,4%	4 932 5 011 -1,6%	9 583 9 523 0,63%	4 611 4 640 -0,63%	4 873 4 890 -0,36%	4 620 4 577 0,95%	4 843 4 843 0,00%	4 903 4 868 0,72%	4 943 4 975 -0,65%	4 865 4 816 1,0%	5 368 5 240 2,4%	5 343	5 639	5 563	5 690	5 853
Operating income (EBITDA) M $	Released Forecast Spread			803 956 -16%			802 863 -7,0%	905 975 -7,2%	1 005 782 29%	1 012 946 7,0%	1 115 991 13%	1 134 1 071 5,9%	1 032 1 065 -3,0%	1 249 1 068 17%	1 202	1 313	1 189	1 247	1 290
Operating profit (EBIT) M $	Released Forecast Spread	1 181 1 168 1,1%	1 457 1 451 0,46%	594 641 -7,3%	1 640 1 519 7,9%	2 221 2 092 6,2%	599 603 -0,62%	695 714 -2,8%	600 571 5,0%	581 601 -3,3%	660 637 3,6%	665 675 -1,5%	602 589 2,2%	773 693 12%	727	824	682	733	773
Pre-Tax Profit (EBT) M $	Released Forecast Spread	973 970 0,31%			1 541 1 425 8,1%		515 584 -12%	629 642 -2,0%	479 465 3,2%	454 484 -6,2%	544 523 4,0%	555 464 20%	487 464 4,9%	664 614 8,2%	618
Net income M $	Released Forecast Spread	522 509 2,7%	681 687 -0,96%	334 347 -3,8%	1 163 1 060 9,7%		324 326 -0,62%	482 427 13%	303 295 2,6%	283 288 -1,6%	370 331 12%	370 362 2,3%	307 282 8,6%	413 379 9,1%	395	463
EPS	Released Forecast Spread	1,71 1,67 2,7%	2,22 2,25 -1,4%	1,09 1,14 -4,6%	3,79 3,39 12%	4,86 4,03 20%	1,06 1,18 -11%	1,56 1,40 11%	0,98 0,99 -0,45%	0,94 0,96 -2,8%	1,22 1,11 10%	1,23 1,20 2,6%	1,03 0,93 10%	1,41 1,27 11%	1,34	1,55
Announcement Date		08/01/2016	08/01/2017	05/03/2018	07/31/2018	07/31/2018	10/30/2018	02/20/2019	05/02/2019	07/30/2019	10/29/2019	02/20/2020	05/06/2020	07/30/2020

Analysis

Fresenius Medical says fourth-quarter operating profit up 3%